Kerala’s Switch to Low-Cost SMA Drug Raises Safety Concerns Among Parents
The Kerala government‘s decision to replace an expensive branded medicine for Spinal Muscular Atrophy (SMA) with a significantly cheaper generic…
For Clinical Trials Only
Read More